<h4>Objective</h4>To evaluate the efficacy of two ultra-low-dose 17beta-estradiol plus norethisterone acetate (NETA) treatment regimens for relieving menopausal symptoms.<h4>Design</h4>A total of 577 postmenopausal women were enrolled, in three treatment groups in a double-blind, randomized, placebo...
No comments yet
Be the first to share your thoughts!